QNCXQuince TherapeuticsQNCX info
$0.73info-0.41%24h
Global rank27759
Market cap$31.38M
Change 7d0.27%
YTD Performance-30.29%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    Quince Therapeutics (QNCX) Stock Overview

    Quince Therapeutics, Inc., a preclinical stage biopharmaceutical company, develops precision therapeutics for debilitating and rare diseases. Its lead compound is NOV004, a systemically administered bone anabolic peptide engineered to target and concentrate at bone fracture sites. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. Quince Therapeutics, Inc. was incorporated in 2012 and is headquartered in South San Francisco, California.

    QNCX Stock Information

    Symbol
    QNCX
    Address
    601 Gateway BlvdSouth San Francisco, CA 94080United States
    Founded
    -
    Trading hours
    9:30 AM - 4:00 PM ET
    Website
    https://www.quincetx.com
    Country
    πŸ‡ΊπŸ‡Έ United States
    Phone Number
    415 910 5717

    Quince Therapeutics (QNCX) Price Chart

    -
    Value:-

    Quince Therapeutics Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.732
    N/A
    Market Cap
    $31.38M
    N/A
    Shares Outstanding
    42.87M
    N/A
    Employees
    21.00
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    Β© 2024 Topstocks.org